These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 9515663)
1. An economic evaluation of vaccination against hepatitis A for frequent travellers. Fenn P; McGuire A; Gray A J Infect; 1998 Jan; 36(1):17-22. PubMed ID: 9515663 [TBL] [Abstract][Full Text] [Related]
2. Vaccination against hepatitis A for travellers. Will alter the dynamics of transmission in Britain. Neal K BMJ; 1995 Jan; 310(6971):61. PubMed ID: 7827576 [No Abstract] [Full Text] [Related]
3. Economic models of hepatitis A virus immunization. O'Connor JB; Imperiale TF; Singer ME Hepatology; 1999 Jul; 30(1):343-5. PubMed ID: 10428627 [No Abstract] [Full Text] [Related]
4. Cost-effectiveness analysis of vaccination against hepatitis A in travellers. Van Doorslaer E; Tormans G; Van Damme P J Med Virol; 1994 Dec; 44(4):463-9. PubMed ID: 7897383 [TBL] [Abstract][Full Text] [Related]
5. Vaccination against hepatitis A for travellers. All relevant costs and consequences should be measured. Hardie R BMJ; 1995 Jan; 310(6971):61-2. PubMed ID: 7827577 [No Abstract] [Full Text] [Related]
6. An economic evaluation of hepatitis A vaccination in Dutch military personnel. Buma AH; Beutels P; van Damme P; Tormans G; van Doorslaer E; Leentvaar-Kuijpers A Mil Med; 1998 Aug; 163(8):564-7. PubMed ID: 9715622 [TBL] [Abstract][Full Text] [Related]
7. A simple cost-decision analysis model comparing two strategies for hepatitis A vaccination. Saab S; Martin P; Yee HF Am J Med; 2000 Aug; 109(3):241-4. PubMed ID: 10974188 [No Abstract] [Full Text] [Related]
8. Should British soldiers be vaccinated against hepatitis A? An economic analysis. Jefferson TO; Behrens RH; Demicheli V Vaccine; 1994 Nov; 12(15):1379-83. PubMed ID: 7887014 [TBL] [Abstract][Full Text] [Related]
9. [Costs of hepatitis A prophylaxis in travelers]. Zaaijer HL; Lelie PN Ned Tijdschr Geneeskd; 1994 May; 138(19):948-9. PubMed ID: 8196787 [No Abstract] [Full Text] [Related]
10. The prevalence of hepatitis A antibodies among Israeli travellers and the economic feasibility of screening before vaccination. Schwartz E; Raveh D Int J Epidemiol; 1998 Feb; 27(1):118-20. PubMed ID: 9563704 [TBL] [Abstract][Full Text] [Related]
11. Economic models of hepatitis A virus immunization. Meltzer M; Messonnier ML Hepatology; 1999 Jul; 30(1):343; author reply 344-5. PubMed ID: 10428626 [No Abstract] [Full Text] [Related]
13. Cost-effectiveness analysis of hepatitis A prevention in travellers. Tormans G; Van Damme P; Van Doorslaer E Vaccine; 1992; 10 Suppl 1():S88-92. PubMed ID: 1335668 [TBL] [Abstract][Full Text] [Related]
14. An economic analysis of different strategies of immunization against hepatitis A virus in developed countries. Das A Hepatology; 1999 Feb; 29(2):548-52. PubMed ID: 9918934 [TBL] [Abstract][Full Text] [Related]
15. Advances in hepatitis A prevention in travellers. Steffen R; Gyurech D J Med Virol; 1994 Dec; 44(4):460-2. PubMed ID: 7897382 [TBL] [Abstract][Full Text] [Related]
16. Is travel prophylaxis worth while? Economic appraisal of prophylactic measures against malaria, hepatitis A, and typhoid in travellers. Behrens RH; Roberts JA BMJ; 1994 Oct; 309(6959):918-22. PubMed ID: 7726905 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis A vaccination by intracutaneous low dose administration: a less expensive alternative. Carlsson U; Brudin L; Eliasson I; Hansson BG Scand J Infect Dis; 1996; 28(5):435-8. PubMed ID: 8953668 [TBL] [Abstract][Full Text] [Related]
18. Preventing hepatitis A infections in travelers to endemic areas. Koff RS Am J Trop Med Hyg; 1995 Dec; 53(6):586-90. PubMed ID: 8561258 [TBL] [Abstract][Full Text] [Related]
19. Travel prophylaxis. Journals should develop guidelines for economic evaluations. Backhouse ME BMJ; 1995 Feb; 310(6976):402. PubMed ID: 7866238 [No Abstract] [Full Text] [Related]